Lilly All Set To Conduct another Successful Trial of Alzheimer's Drug

Lilly All Set To Conduct another Successful Trial of Alzheimer's Drug

A recent research has shed light on an experimental Alzheimer's drug, by Eli Lilly & Company, which might be able to deal with the mild cases. However, they would have to go for another trial in order to confirm that the drug, solanezumab, is effective enough.

The makers have apparently observed that the drug is capable enough to slow memory decline, while they conducted the research on over 1000 patients earlier. After the research, they found that some 34% mild Alzheimer's patients faced reduced mental decline for a period of 18 months.

Thus before approaching U. S. regulatory approval, the makers are going for another trial to confirm their results. There are fair chances of the research to be over by the second half of 2015, and hopefully, the drug would be able to make its way in the market in 2017.

"We are committed to working with the F. D. A. and other regulatory authorities to bring solanezumab to the millions of patients and caregivers suffering from this devastating disease who urgently need this potential treatment", said David Ricks, a senior vice president at Lilly and president of Lilly Bio-Medicines.

Though the shares of the company saw a rise of 16% after the initial results in August, they faced a drop of $1.60, or 3.2%, to $49, after the announcement of the second trial.


FrenchTribune Specials

Heavy Milk Consumption could be Harmful for Women: Study

A study conducted by Swedish researchers has found that women who drink three or more glasses of milk per day could face twice the risk of death and heart disease. According to the study, those women who consumed milk heavily had about 44% increased risk of cancer, as compared to women who drink one or less glass of milk.

On the other...

Most Popular

Crew saves two Beached Pilot Whales at Sunbury Cove

Crew members have been able to save two pilot whales at...

Weight-loss surgery can lead to severe headaches

After weight reduction surgery, a few patients may be at...

Toyota sells partial stake in Tesla Motors

In a recent announcement, world's biggest automaker...

‘PhotoMath’ – a free mobile which can solve mathematical problems almost instant

London-based MicroBlink's 'PhotoMath' free mobile app is...

Poll

Can Greece Come out of Economic Problems: